Hemodynamic Effects of Short-term Infusion of a Vasopressin V1A/V2 Receptor Antagonist Conivaptan in Patients Withchronic Heart Failure During Submaximal Exercise
Overview
Overview
Journal
Am Heart J
Specialty
Cardiology & Vascular Diseases
Date
2018 Jul 31
PMID
30057012
Citations
2
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction.
Vishram-Nielsen J, Tomasoni D, Gustafsson F, Metra M Drugs. 2022; 82(4):375-405.
PMID: 35113350 PMC: 8820365. DOI: 10.1007/s40265-021-01666-z.
Copeptin as a predictive marker of incident heart failure.
Schill F, Timpka S, Nilsson P, Melander O, Enhorning S ESC Heart Fail. 2021; 8(4):3180-3188.
PMID: 34056865 PMC: 8318511. DOI: 10.1002/ehf2.13439.